Document is current
Any future updates will be listed below
-
Authors
Shen, Max W.
Zhao, Kevin T. http://orcid.org/0000-0003-3440-2094
Liu, David R. http://orcid.org/0000-0003-0346-5033
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB031172, R01 EB027793)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
Howard Hughes Medical Institute (Liu Investigatorship)
- License Information
-
More Information
Article History
Received: 25 November 2020
Accepted: 9 August 2021
First Online: 11 October 2021
Competing interests
: D.R.L. is a co-founder of Beam Therapeutics, Prime Medicine, Editas Medicine and Pairwise Plants, companies that use genome editing technologies.
